Zymeworks Inc.
Zymeworks is a biotechnology company managing a portfolio of healthcare assets and developing novel, multifunctional biotherapeutics. They focus on optimizing cash flows from licensed products like Ziihera® (zanidatamab-hrii) and supporting early-stage development of innovative medicines. Their therapeutic platforms and integrated drug development engine engineer differentiated antibody-based therapeutics for themselves and partners. They aim to transform areas of high unmet medical need.
Official Registry
AI Quality Analysis
Trust Score Breakdown
Quick Links
Sivuston kohokohdat
🌟 Vastaavat luotettavat yritykset
Metagenomi, Inc.
Metagenomi is an in vivo genome editing company creating curative genetic medicines using proprietary technologies. They leverage metagenomics to discover editing tools potentially capable of correcting any type of genetic mutation. The company focuses on diseases with well-understood biology and clear regulatory pathways, and intends to expand their pipeline through genetic editing capabilities.
ARCTICZYMES TECHNOLOGIES ASA
ArcticZymes Technologies on bioteknologiayritys, joka on erikoistunut entsyymien kehittämiseen ja tuotantoon. He tarjoavat nukleaaseja biolääketuotantoon ja molekyylidiagnostiikkaan, mukaan lukien suola-aktiiviset nukleaasit (SAN). Yritys on tunnettu polymeraaseistaan ja entsyymeistään, joita käytetään tutkimus- ja teollisuussovelluksissa.
ACD PHARMACEUTICALS AS
ACD Pharma is a Norwegian R&D company developing biocontrol products based on bacteriophages, focusing on combating harmful bacteria in animals and humans. They launched Custus®YRS, the world's first bacteriophage product for aquaculture. They collaborate with pharmaceutical and scientific teams to fight antibiotic resistance, extending their advancements across sectors.